Radhika Balasubramani

Director, Technical Product Steward - Antibody Drug Conjugates Merck & Co.

Seminars

Wednesday 5th November 2025
Summary Discussion: Breaking Down the Top Opportunities to Overcome ADC Manufacturing & Supply Chain Bottlenecks
3:00 pm

Join this closing discussion session with leaders in ADC CMC field to break down the key learnings from the two days presentations and discussion. With your fellow speakers and attendees, discuss, debate and evaluate the opportunities and challenges in ADC manufacturing timelines, navigating supply with multiple outsourcing partners, technology transfer and scale up, regulatory CMC, and more

Wednesday 5th November 2025
Panel Discussion: Exploring Opportunities With ADC Regulatory CMC & Making the Most of Sponsor- Regulator Interactions
2:30 pm
  • ADC regulatory submissions under accelerated timelines: Is it clear what is must have versus nice to have?
  • Comparing ADC regulatory CMC guidelines across global Health authorities
  • Assessing prioritizations for future industry-regulator interactions and science-based justifications for alternative control strategies
Radhika Balasubramani - 16th World ADC San Diego